Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2019. Start Trial.
Date Value
October 02, 2026 136.06M
October 01, 2026 117.62M
September 30, 2026 122.65M
September 29, 2026 132.71M
September 28, 2026 136.06M
September 25, 2026 147.81M
September 24, 2026 162.06M
September 23, 2026 172.96M
September 22, 2026 219.93M
September 21, 2026 213.22M
September 18, 2026 228.31M
September 17, 2026 233.35M
September 16, 2026 218.25M
September 15, 2026 235.86M
September 14, 2026 288.70M
September 11, 2026 258.51M
September 10, 2026 260.18M
September 09, 2026 288.70M
September 08, 2026 349.08M
September 04, 2026 382.62M
September 03, 2026 384.30M
September 02, 2026 399.40M
September 01, 2026 354.11M
August 31, 2026 322.24M
August 28, 2026 323.92M
Date Value
August 27, 2026 367.53M
August 26, 2026 345.72M
August 25, 2026 340.69M
August 24, 2026 320.56M
August 21, 2026 325.60M
August 20, 2026 335.66M
August 19, 2026 320.56M
August 18, 2026 288.70M
August 17, 2026 285.34M
August 14, 2026 261.86M
August 13, 2026 255.15M
August 12, 2026 278.63M
August 11, 2026 268.57M
August 10, 2026 270.25M
August 07, 2026 268.57M
August 06, 2026 263.54M
August 05, 2026 255.15M
August 04, 2026 265.21M
August 03, 2026 251.80M
July 31, 2026 250.12M
July 30, 2026 256.83M
July 29, 2026 240.06M
July 28, 2026 258.51M
July 27, 2026 256.83M
July 24, 2026 251.80M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Agenus, Inc. 620.93M
Amgen, Inc. 261.20B
BioCryst Pharmaceuticals, Inc. 2.569B
Imunon, Inc. 6.953M
Curis, Inc. -3.007M

Enterprise Value Related Metrics